15.4 C
California
Tuesday, October 20, 2020

2nd COVID-19 Vaccine Trial Paused Over Unexplained Illness

FILE – This September 2020 photo provided by Johnson & Johnson shows a single-dose COVID-19 vaccine being developed by the company. A late-stage study of Johnson & Johnsons COVID-19 vaccine candidate has been paused while the company investigates whether a study participants unexplained illness is related to the shot, the company announced Monday, Oct. 12, 2020. (Cheryl Gerber/Courtesy of Johnson & Johnson via AP, File)

A latestage study of Johnson & Johnsons COVID19 vaccine candidate has been paused while the company investigates whether a study participants unexplained illness is related to the shot.

NEW BRUNSWICK, N.J.: A late-stage study of Johnson & Johnsons COVID-19 vaccine candidate has been paused while the company investigates whether a study participants unexplained illness is related to the shot.

The company said in a statement Monday evening that illnesses, accidents and other so-called adverse events are an expected part of any clinical study, especially large studies, but that its physicians and a safety monitoring panel would try to determine what might have caused the illness.

The pause is at least the second such hold to occur among several vaccines that have reached large-scale final tests in the U.S.

The company declined to reveal any more details about the illness, citing the participants privacy.

Temporary stoppages of large medical studies are relatively common. Few are made public in typical drug trials, but the work to make a coronavirus vaccine has raised the stakes on these kinds of complications.

Companies are required to investigate any serious or unexpected reaction that occurs during drug testing. Given that such tests are done on tens of thousands of people, some medical problems are a coincidence. In fact, one of the first steps the company said it will take is to determine if the person received the vaccine or a placebo.

The halt was first reported by the health news site STAT.

Final-stage testing of a vaccine made by AstraZeneca and Oxford University remains on hold in the U.S. as officials examine whether an illness in its trial poses a safety risk. That trial was stopped when a woman developed severe neurological symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, the company has said. That company’s testing has restarted elsewhere.

Johnson & Johnson was aiming to enroll 60,000 volunteers to prove if its single-dose approach is safe and protects against the coronavirus. Other vaccine candidates in the U.S. require two shots.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Speak Your Mind

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Get in Touch

211FansLike
33FollowersFollow
41FollowersFollow

Recommend for You

Trump Threatens To ‘Fire’ Florida Governor If He Loses The State In November

Topline President Trump on Friday said he would blame Florida Gov. Ron DeSantis if he lost the potentially pivotal battleground state in the presidential...

‘This is insanity’: Doctors slam Trump’s drive to greet supporters outside Walter Reed hospital

US President Trump waves from the back of a car outside of Walter Reed Medical Center in Bethesda, Maryland on Ocotber 4, 2020.Alex Edelman...

Why Tech Giants Limited The Spread Of NY Post Story On Biden

OAKLAND, California: When Facebook and Twitter moved quickly this week to limit the spread of an unverified political story published by the conservative-leaning...

International Flights: India Has Established Air Bubble Pact With These Countries | Details Here

International Flights Latest News: After establishing Air Bubble arrangements with...

After Singapore greenlights cruises to nowhere, Genting’s Dream Cruises says inquiries are ‘coming nonstop’

SINGAPORE — First there were flights to nowhere, now there are cruises to nowhere. This week, Singapore announced a pilot program where cruises will make round...

Related Articles

Away Co-CEO Steph Korey Will Step Down, Again

TOPLINE In recent weeks, one high-profile female founder after another has stepped down...

Oil Falls Second Day As Rising Virus Cases Spur...

TOKYO: Oil prices fell for a second day on Wednesday, extending large losses from...

New ‘Wonder Woman 1984’ Release Date Offers A Chance...

Gal Gadot in Patty Jenkins' 'Wonder Woman 1984' ...